Aethlon medical announces financial results for the fiscal year ended march 31, 2024 and provides corporate update

Conference call to be held today at 4:30 p.m. et san diego , june 27, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal year ended march 31, 2024 and provided an update on recent developments.
AEMD Ratings Summary
AEMD Quant Ranking